New treatment Xadago to help 100,000 Canadians living with Parkinson’s

News

Author: Parkinson's Life editorsPublished: 5 May 2017

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

More than 100,000 Canadians living with Parkinson’s will benefit from a new product to be launched in the country.

The drug known as ‘Xadago’, currently readily available in several countries across Europe, helps control motor symptoms and complications over a 24-month period.

Xadago will be the first new oral treatment for Parkinson’s in almost 15 years in Canada. On 21 March 2017 the Food and Drug Administration in the US approved the use of Xadago for the treatment of Parkinson’s as an add-on therapy to levodopa/carbidopa.

Go Back

Share this story

Comments


Related articles


Europe

Scientific art: stunning Parkinson’s photos reveal beauty of the brain

Winning photo showcases the beautiful complexity of brain cells

READ MORE
Elan and Amanda high-res

Interviews

Speaking out: Dad with Parkinson’s calls for better access to speech therapy

Documentary raises awareness for Parkinson’s speech therapy

READ MORE

Perspectives

Parkinson’s website could put lives at risk, says clinical director of Parkinson’s UK

Claims made by Fight Parkinson’s are “absolutely unsubstantiated”

READ MORE